Weight loss pills could help tackle obesity in poorer countries, experts say

Oral medications are in development to provide alternative to injectables such as Wegovy that must be kept in fridge

Newly developed weight loss pills could have a big impact on tackling obesity and diabetes in low- and middle-income countries, experts have said.

Weight loss jabs such as Wegovy and Mounjaro, that contain the drugs semaglutide and tirzepatide respectively, have become popular in countries including the UK after trials showed they can help people lose more than 10% of their body weight. Medications containing semaglutide and tirzepatide can also be used to help control diabetes.